Risk management of coronary heart disease-prevention;Präventives risikomanagement der koronaren herzerkrankung

Wiener Medizinische Wochenschrift

Volumn 154, Issue 11-12, 2004, Pages 257-265

  Dorner, Thomas ^a   Rieder, Anita ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cardiovascular disease; Epidemiology; Health promotion; Prevention; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ALPHA TOCOPHEROL; BETA CAROTENE; CHOLESTEROL; ESTROGEN; PROGESTERONE;

ALCOHOL ABUSE; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; EPIDEMIOLOGICAL DATA; EXERCISE; FAMILY HISTORY; FITNESS; HEALTH PROGRAM; HEALTH PROMOTION; HEART INFARCTION; HORMONE DETERMINATION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LIFESTYLE; METABOLIC SYNDROME X; MORTALITY; ORAL CONTRACEPTION; PREGNANCY; REVIEW; RISK FACTOR; RISK MANAGEMENT; RISK REDUCTION; SEX DIFFERENCE; SOCIOECONOMICS; TREATMENT OUTCOME;

ADULT; AGED; AUSTRIA; CAUSE OF DEATH; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH EDUCATION; HEALTH PROMOTION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 3142736020     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-004-0073-0     Document Type: Review

References (63)

1. Murray DM, Hannan PJ, Jacobs DR, McGovern PJ, Schmid L, Baker WL, Gray C (1994) Assessing intervention effects in the Minnesota Heart Health Program. Am J Epidemiol 139(1): 91-103
2. Statistik Austria (2003) Statistisches Jahrbuch 2003. www.statistik.at
3. Peelers A, Mamun AA, Willekens F, Bonneux L (2002) A cardiovascular life history, a life course analysis of the original Framingham Heart Study cohort. Eur Heart J 23(6): 458-466
4. Hennekens CH (2003) Primary prevention of cardiovascular disease and stroke. UpToDate, www.uptodate.com
5. Rieder A (2001) Statistische Mitteilungen zur Gesundheit in Wien 2000/2, Herz-Kreislauferkrankungen in Wien. Magistratsabteilung für Angelegenheiten der Landessanitätsdirektion, Dezernat II - Gesundheitsplanung, 2000/2, Wien
6. Levenson JW, Skerrett PJ, Gaziano JM (2002) Reducing the global burden of cardiovascular disease: the role of risk factors. Prev Cardiol 5(4): 188-199
7. European Guidelines on CVD Prevention (2003) ESC Committee for Practice Guidelines to improve the quality of clinical practice and patient care in Europe, www.escardio.org
8. S. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC (2000) Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 343(1): 16-22
9. Negri E, La Vecchia C, D'Avanzo B, Nobili A, La Malfa RG (1994) Acute myocardial infarction: association with time since stopping smoking in Italy. GISSI-EFRIM Investigators. Gruppo Italiano per lo Studio della Soprav-vivenza nell'Infarto. Epidemiologia dei Fattori di Rischio dell'Infarto Miocardico. J Epidemiol Community Health 48(2): 129-133
10. Critchley JA, Capewell S (2003) Mortality risk reduction associated with smoking in patients with coronary heart disease: a systematic review. JAMA 290: 86
11. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchner D, Ettinger W, Heath GW, King AC, et al (1995) Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 273(5): 402-407
12. Myers J, Prakash M, Froehlicher V, et al (2002) Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346: 793
13. Hubert HB, Feinleib M, McNamara PM, Castelli WP (1983) Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67(5): 968-977
14. Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, Hennekens CH (1995) Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA 273(6): 461-465
15. Krauss RM, Winston M, Fletcher RN, Grundy SM (1998) Obesity: impact of cardiovascular disease. Circulation 98(14): 1472-1476
16. Rosenson R (2004) Screening guidelines for dyslipidemia. UpToDate, www.uptodate.com
17. Collins R, Peto R, MacMahon S, et al (1990) Blood pressure, stroke and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335: 827
18. Kannel WB, Gordon T, Schwartz MJ (1971) Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol 27(4): 335-346
19. Wilking SV, Belanger A, Kannel WB, D'Agostino RB, Steel K (1988) Determinants of isolated systolic hypertension. JAMA 260(23): 3451-3455
20. Hennekens C, Cannon CP (2004) Risk factor reduction (secondary prevention) of cardiovascular disease and stroke. UpToDate, www.uptodate.com
21. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97(18): 1837-1847
22. Pyorala M, Miettinen H, Laakso M, Pyorala K (2000) Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality: the 22-year follow-up results of the Helsinki Policemen Study. Diabetes Care 23(8): 1097-1102
23. Wilson PWF, Grundy SM (2003) The metabolic syndrome. A practical guide to origins and treatment: part II. Circulation 108: 1537-1540
24. Third report of the National Cholesterol Education Program (NCEP) (2002) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): Final report. US Department of Health and Human Services; Public Health Service; National Institutes of Health; National Heart, Lung, and Blood Institute. Circulation 106: 3143-3421
25. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285(19): 2486-2497
26. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among us adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA 287: 356-359
27. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M (2003) Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck study. Int J Obes 27: 1283-1289
28. Alexander CM, Landsman PB, Teutsch SM, Haffner SM (2003) NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52: 1210-1214
29. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716
30. Haffner S, Taegtmeyer H (2003) Epidemic obesity and the metabolic syndrome. Circulation 108: 1541-1545
31. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RP, Lachin JM, Walker EA, Nathan DM (2002) Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403
32. McAuley KA, Williams SM, Mann JI, Goulding A, Chisholm A, Wilson N, Story G, McLay RT, Haper MJ, Jones IE (2002) Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trial. Diabetes Care 25: 445-452
33. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al (2001) Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343-1350
34. Torjesen PA, Birkeland KI, Anderssen SA, Hjermann I, Holme I, Urdal P (1997) Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial. Diabetes Care 20: 26-31
35. Pan XR, Li GW, Hu YH, Yang WY, An ZX, Hu ZX, et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20: 537-544
36. World Health Organization (2003) Diet, nutrition and the prevention of chronic diseases. Report of a Joint WHO/FAO Expert Consultation. WHO, Geneva
37. Wilson PWF, Culleton BF (2004) Overview of the risk factors for cardiovascular disease. UpToDate, www.upto date.com
38. Menhem K, Dotevall A, Wilhelmsen L, Rosengren A (2000) Social gradients in cardiovascular risk factors and symptoms of Swedish men and women: the Goteborg MONICA Study 1995. J Cardiovasc Risk 7(5): 359-368
39. Mackenbach JP, Kunst AE, Groenhof F, Borgan J-K, Costa G, Faggiano F, Jozan P, Leinsalu M, Martikainen P, Rychtarikova J, Valkonen T (1999) Socioeconomic inequalities in mortality among women and among men: an international study. Am J Public Health 89(12): 1800-1806
40. Douglas PS, Poppas A (2003) Determinants and management of cardiovascular risk in women. UpToDate, www.uptodate.com
41. Mosca L, Grundy SM, Judelson D, et al (1999) Guide to preventive cardiology for women. AHA/ACC scientific statement, consensus panel statement. Circulation 2480-2484
42. Hu FB, Grodstein F, Hennekens CH, et al (1999) Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 159: 1061
43. Colditz GA, Willett WC, Stampfer MJ, et al (1987) Menopause and the risk of coronary heart disease in women. N Engl J Med 316: 1105
44. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288(3): 321-333
45. Hulley S, Grady D, Bush T, et al for the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605
46. Rosenberg L, Palmer JR, Rao S, Shapiro S (2001) Low-dose oral contraceptive use and the risk of myocardial infarction. Arch Intern Med 161: 1065
47. Ness RB, Harris T, Cobb J, et al (1993) Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med 328: 1528
48. Lawlor DA, Emberson JR, Ebrahim S, et al (2003) Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Findings from the British Women's Heart and Health Study and the British Regional Heart Study. Circulation 107: 1260
49. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, Haan CK, Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC, Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenck-Gustafsson K, Sila CA, Smith SC Jr, Sopko G, Taylor AL, Walsh BW, Wenger NK, Williams CL (2004) Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 109(5): 672-693
50. Mosca L (2004) Cardiology patient page. Heart disease prevention in women. Circulation 109(10): e158-160
51. Heart Plan for Europe (2002) A summary of evidence supporting a European plan to reduce the impact of cardiovascular disease in Europe. Source document from the European Society of Cardiology, 21 March 2002
52. Pearson TA, Bazzarre TL, Daniels SR, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Hong Y, Mensah GA, Sallis JF Jr, Smith S Jr, Stone NJ, Taubert KA (2003) American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation 107(4): 645-651
53. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P (1994) Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 309(6946): 23-27
54. Smith C, Moore L, Trickey H (1994) Community-based cardiovascular disease prevention. A review of the effectiveness of health education and health promotion. Commission of the European Communities, Utrecht
55. Fortmann SP, Williams PT, Hulley SB, Haskell WL, Farquhar JW (1981) Effect of health education on dietary behavior: the Stanford Three Community Study. Am J Clin Nutr 34(10): 2030-2038
56. Winkleby MA, Taylor CB, Jatulis D, Fortmann SP (1996) The long-term effects of a cardiovascular disease prevention trial: the Stanford Five-City Project. Am J Public Health 86(12): 1773-1779
57. Giampaoli S, Urbinati GC, Menotti A, Ricci G (1991) Short term changes in cardiovascular risk factors in the Di.S.Co. Intervention Project. Research Group of the DI.S.Co. Project. Eur J Epidemiol 7(4): 372-379
58. Domenighetti G, Locatelli A, Barazzoni F, Luraschi P, Casabianca A (1989) The medical team and the campaign for primary prevention of cardiovascular diseases in the Tessin canton. Soz Präventivmed 34(3): 115-118
59. Nutbeam D, Smith C, Murphy S, Catford J (1993) Maintaining evaluation designs in long term community based health promotion programmes: Heartbeat Wales case study. J Epidemiol Community Health 47(2): 127-133
60. Murray CJ, Lopez AD (1997) Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349(9061): 1269-1276
61. Fortmann SP, Varady AN (2000) Effects of a community-wide health education program on cardiovascular disease morbidity and mortality: the Stanford Five-City Project. Am J Epidemiol 152(4): 316-323
62. Rieder A (2000) Ein Herz fur Wien. Wissenschaftliches Konzept für ein Herz-Kreislauf-Präventionsprogramm im Rahmen des Wiener Gesundheitsförderungsprogrammes. MA-L Abteilung für Gesundheitsplanung
63. Rieder A, Dorner T, Hübel U, Antes G, Strunz B, Schmidl H (2003) "Ein Herz für Wien". Eine Stadt widmet sich der Herzgesundheit ihrer Bewohner. Wien Klin Wochenschr Magazin 19-20a